Techniques characterizing the coronary atherosclerotic plaque: Influence on clinical decision making?

Journal of the American College of Cardiology

Volumn 36, Issue 1, 2000, Pages 13-21

  Pasterkamp, Gerard ^a,b   Falk, Erling ^c   Woutman, Hein ^a,b   Borst, Cornelius ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSCOPY; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CATHETER; CHEMICAL COMPOSITION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ELASTOGRAPHY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMAGING; INFLAMMATION; INTRAVASCULAR ULTRASOUND; MEDICAL DECISION MAKING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REVIEW; RISK FACTOR; SCINTIANGIOGRAPHY; STENOSIS; TECHNIQUE; THERMOMETRY; THICKNESS;

CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DECISION SUPPORT TECHNIQUES; DIAGNOSTIC IMAGING; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE PROGRESSION; HUMANS; PROGNOSIS;

EID: 0033911120     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00677-X     Document Type: Review

References (81)

1. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb. 15:1995;1512-1531.
2. Falk E., Shah P.K., Fuster V. Coronary plaque disruption. Circulation. 92:1995;657-671.
3. Fuster V. Lewis A Conner Memorial Lecture mechanisms leading to myocardial infarction: insights from studies of vascular biology . Circulation. 90:1994;2126-2146.
4. Davies M.J., Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med. 310:1984;1137-1140.
5. Ambrose J.A., Tannenbaum M.A., Alexopoulos D., et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 12:1988;56-62.
6. Little W.C., Constantinescu M., Applegate R.J., et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 78:1988;1157-1166.
7. Alderman E.L., Corley S.D., Fisher L.D., et al. Five year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol. 22:1993;1141-1154.
8. Davies M.J., Richardson P.D., Woolf N., Katz D.R., Mann J. Risk of thrombosis in human atherosclerotic plaques role of extracellular lipid, macrophage, and smooth muscle cell content . Br Heart J. 69:1993;377-381.
9. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:1994;36-44.
10. Moreno P.R., Falk E., Palacios I.F., Newell J.B., Fuster V., Fallon J.T. Macrophage infiltration in acute coronary syndromes implications for plaque rupture . Circulation. 90:1994;775-778.
11. Mann J.M., Davies M.J. Vulnerable plaque relation of characteristics to degree of stenosis in human coronary arteries . Circulation. 94:1996;928-931.
12. Fishbein M.C., Siegel R.J. How big are coronary atherosclerotic plaques that rupture? Circulation. 94:1996;2662-2666.
13. Richardson P.D., Davies M.J., Born G.V.R. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 2:1989;941-944.
14. Loree H.M., Kamm R.D., Strigfellow R.G., et al. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Circ Res. 71:1992;850-858.
15. Cheng G.C., Loree H.M., Kamm R.D., Fishbein M.C., Lee R.T. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions a structural analysis with histopathological correlation . Circulation. 87:1993;1179-1187.
16. Loree H.M., Tobias B.J., Gibson L.J., Kamm R.D., Small D.M., Lee R.T. Mechanical properties of model atherosclerotic lesion lipid pools. Arterioscler Thromb. 14:1994;230-234.
17. Lee R.T., Schoen F.J., Loree H.M., Lark M.W., Libby P. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis implications for plaque rupture . Arterioscl Thromb Vasc Biol. 16:1996;1070-1073.
18. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503.
19. Gertz S.D., Roberts W.C. Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol. 66:1990;1368-1372.
20. Davies M.J., Woolf N., Rowles P., Richardson P.D. Lipid and cellular constituents of unstable human aortic plaques. Basic Res Cardiol. 89:1994;133-139.
21. Small D.M. Progression and regression of atherosclerotic lesions insight from lipid physical biochemistry . Arteriosclerosis. 8:1988;103-129.
22. Lundberg B. Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis. 56:1985;93-110.
23. Galis Z.S., Galina Sukhova G.K., Kanshofer R., et al. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading metalloproteinases. Proc Natl Acad Sci USA. 92:1995;402-406.
24. Knox J.B., Sukhova G.K., Whittemore A.D., Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation. 95:1997;205-212.
25. Gussenhoven E.J., Essed C.E., Lancee C.T., et al. Arterial wall characteristics determined by intravascular ultrasound imaging an in vitro study . J Am Coll Cardiol. 14:1989;947-952.
26. Tobis J.M., Mallery J.A., Gessert J., et al. Intravascular ultrasound cross-sectional arterial imaging before and after balloon angioplasty in vitro. Circulation. 80:1989;873-882.
27. Hermiller J.B., Tenaglia A.N., Kisslo K.B., et al. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol. 71:1993;665-668.
28. Losordo D.W., Rosenfield K., Kaufman J., Pieczek A., Isner J.M. Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. Circulation. 89:1994;2570-2577.
29. Pasterkamp G., Borst C., Post M.J., et al. Atherosclerotic arterial remodeling in the superficial femoral artery individual variation in local compensatory enlargement response . Circulation. 93:1996;1818-1825.
30. Peters R.J.G., Kok W.E.M., Havenith M.G., Rijsterborgh H., van der Wal A.C., Visser C.A. Histopathologic validation of intracoronary ultrasound imaging. J Am Soc Echocardiography. 7:1994;230-241.
31. Potkin B.N., Bartorelli A.L., Gessert J.M., et al. Coronary artery imaging with intravascular high frequency ultrasound. Circulation. 81:1990;1575-1585.
32. Ge J., Baumgart D., Haude M., et al. Role of intravascular ultrasound imaging in identifying vulnerable plaques. Herz. 24:1999;32-41.
33. Mintz G.S., Pichard A.D., Popma J.J., et al. Determinants and correlates of target lesion calcium in coronary artery disease a clinical, angiographic and intravascular ultrasound study . J Am Coll Cardiol. 29:1997;268-274.
34. Hodgson J. McB, Reddy K.G., Suneja R., Nair R.N., Lesnefsky E.J., Sheenan H.M. Intracoronary ultrasound imaging correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty . J Am Coll Cardiol. 21:1993;35-44.
35. Pasterkamp G., Schoneveld A.H., van der Wal A.C., et al. The relation of arterial geometry with luminal narrowing and plaque vulnerability the remodeling paradox . J Am Coll Cardiol. 32:1998;655-662.
36. Nishioka T., Luo H., Nagai T., et al. Impact of coronary artery remodeling on clinical manifestations of patients with de novo coronary artery lesions. J Am Coll Cardiol. 29:(Suppl):1997;125A.
37. Schwarzacher S., Huegel H., Filardo S.D., Lee D.P., Yeung A.C. Ruptured plaques have greater degree of remodeling that stable lesions an IVUS study . Circulation. 98:(Suppl):1998;750.
38. Smits PC, Pasterkamp G, de Jaegere PJ, Eefting FD, Stella PR, Borst C. Coronary artery disease: arterial remodeling and clinical presentation. Heart (in press).
39. De Korte C.L., Cespedes E.I., van der Steen A.F.W., Lancee C.T. Intravascular ultrasound elastography of human arteries feasibility studies in phantoms . Ultrasound Med Biol. 23:1997;735-746.
40. De Korte C.L., van der Steen A.F.W., Cespedes E.I., Pasterkamp G. Intravascular elastography an in vitro study . Ultrasound Med Biol. 24:1998;401-408.
41. De Korte C.L., Cespedes E.I., van der Steen A.F.W., Pasterkamp G., Bom N. Intravascular ultrasound elastography assessment and imaging of elastic properties of diseased arteries and vulnerable plaque . Eur J Ultrasound. 7:1998;219-224.
42. Siegel R.J., Ariani M., Fishbein M.C., et al. Histopathologic validation of angioscopy and intravascular ultrasound. Circulation. 84:1991;109-117.
43. Thieme T., Wernecke K.D., Meyer R., et al. Angioscopic evaluation of atherosclerotic plaques validation by histomorphologic analysis and association with stable and unstable coronary syndromes . J Am Coll Cardiol. 28:1996;1-6.
44. Uchida Y., Nakamura F., Tomaru T., et al. Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J. 130:1995;195-203.
45. White C.J., Ramee S.R., Collins T.J., et al. Coronary thrombi increase PTCA risk angioscopy as a clinical tool . Circulation. 93:1996;253-258.
46. Van Belle E., Lablanche J.M., Bauters C., Renaud N., Mc Fadden E.P., Bertrand M.E. Coronary angioscopic findings in the infarct-related vessel within 1 month of acute myocardial infarction natural history and the effect of thrombolysis . Circulation. 97:1998;26-33.
47. Skinner M.P., Yuan C., Mitsumori L., et al. Serial MRI of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med. 1:1995;69-73.
48. Lin W., Abendschein D.R., Haacke E.M. Contrast-enhanced magnetic resonance angiography of carotid arterial wall in pigs. J Magn Reson Imaging. 7:1997;183-190.
49. Kaneko E., Lipidi S., Batkoff B.W., et al. Serial MRI measurements of atherosclerosis and lumen stenosis in vivo in nonhuman primates. Circulation. 94:(Suppl):1996;I346.
50. Fayad Z.A., Fallon J.T., Shinnar M., et al. Noninvasive in vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 98:1998;1541-1547.
51. Toussaint J.F., LaMuraglia G.M., Southern J.F., Fuster V., Kantor H.L. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic and thrombotic components of human atherosclerosis in vivo. Circulation. 94:1996;932-938.
52. Correia L.C.L., Atalar E., Kelemen M.D., et al. Intravascular magnetic resonance imaging of aortic atherosclerotic plaque composition. Arterioscl Thromb Vasc Biol. 17:1997;3626-3632.
53. Zimmerman-Paul G.G., Quick H.H., Vogt P., von Schulthess G.K., Kling D., Debatin J.F. High resolution intravascular magnetic resonance imaging monitoring of plaque formation in heritable hyperlipidemic rabbits . Circulation. 99:1999;1054-1061.
54. Vallabhajosula S., Fuster V. Atherosclerosis imaging techniques and the evolving role of nuclear medicine . J Nucl Med. 38:1997;1788-1796.
55. Vallabhajosula S., Paidi M., Badimon J.J., et al. Radiotracers for low density lipoprotein biodistribution studies in vivo technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations . J Nucl Med. 29:1988;1237-1245.
56. Fischman A.J., Rubin R.H., Khaw B.A., et al. Radionuclide imaging of experimental atherosclerosis with non-specific polyclonal immunoglobulin G. J Nucl Med. 30:1989;1095-1100.
57. Demacker P.N.M., Dormans T.P.J., Koenders E.B., Corstens F.H.M. Evaluation of Indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy effect of age and treatment with antioxidants or ethinylestradiol . J Nucl Med. 34:1993;1316-1321.
58. Narula J., Petrov A., Bianchi C., et al. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimerical Z2D3 F(ab′)2 specific for the proliferating smooth muscle cells of human atheroma imaging with conventional and negative charge-modified antibody fragments . Circulation. 92:1995;474-484.
59. Smyth J.V., Dodd P.D.F., Walker M.G. Indium-111 platelet scintigraphy in vascular disease. Br J Surg. 82:1995;588-595.
60. Moriwaki H., Matsumoto M., Handa N., et al. Functional and anatomic evaluation of carotid atherosclerosis a combined study of indium 111 platelet scintigraphy and B-mode ultrasonography . Arterioscl Thromb Vasc Biol. 15:1995;2234-2240.
61. Casscells W., Hathorn B., David M., et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques possible implications for plaque rupture and thrombosis . Lancet. 347:1996;1447-1449.
62. Stefanadis C., Diamantopoulos L., Vlachopoulos C., et al. Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo. Circulation. 99:1999;1965-1971.
63. Huang D., Swanson E.A., Lin C.P., et al. Optical coherence tomography. Science. 254:1991;1178-1181.
64. Brezinski M.E., Tearney G.J., Bouma B.E., et al. Optical coherence tomography for optical biopsy properties and demonstration of vascular pathology . Circulation. 93:1996;1206-1213.
65. Brezinski M.E., Tearney G.J., Weissman N.J., et al. Assessing atherosclerotic plaque morphology comparison of optical coherence tomography and high frequency intravascular ultrasound . Heart. 77:1997;397-402.
66. Römer TJ, Brennan JF III, Buschman HPJ. Raman spectroscopy of atherosclerosis: towards real-time in vivo histochemistry and pathology. In: Van der Wall, editor. Advanced Imaging in Coronary Artery Disease. Dordrecht: Kluwer Academic Publishers, 1998:29-53.
67. Buschman HP, Römer TJ, van der Laarse A, Bruschke AV, Puppels GJ. Human coronary atherosclerosis studied in vitro by catheter based transluminal Raman spectroscopy. Proc BIOS/SPIE (in press).
68. Römer T.J., Brennan J.F. III, Fitzmaurice M., et al. Histopathology of human coronary atherosclerosis by quantifying its chemical composition with Raman spectroscopy. Circulation. 97:1998;878-885.
69. Brennan J.F. III, Römer T.J., Lees R.S., Tercyak A.M., Kramer J.R. Jr, Feld M.S. Determination of human coronary artery composition by Raman spectroscopy. Circulation. 96:1997;99-105.
70. Römer T.J., Brennan J.F. III, Bakker-Schut T.C., et al. Raman spectroscopy for quantifying cholesterol in intact coronary artery wall. Atherosclerosis. 141:1998;117-124.
71. SoRelle R. Many Cardiologists still unsure of electron beam computed tomography's benefit as a screening tool. Circulation. 99:1999;3090-3091.
72. Moreno P.R., Lodder R.A., O'Conner W.N., et al. Characterization of vulnerable plaques by near infrared spectroscopy in an atherosclerotic rabbit model (abstr). J Am Coll Cardiol. 33:(Suppl A):1999;66A.
73. Marcu L., Maarek J.M., Fishbein M., Grundfest W. Atherosclerotic lesions classification by time resolved laser induced fluorescence spectroscopy clinical identification of lipid rich lesions (abstr) . J Am Coll Cardiol. 33:(Suppl A):1999;66A.
74. Konings MK, Bouma C, Mali WPTM, Viergever MA. 2D intravascular electrical impedance technique using a non-iterative, non-linear reconstruction algorithm. In: Duncan, Gindi G, editors. Information Processing in Medical Images. Heidelberg: Springer-Verlag, Lecture notes in computer sciences 1997;1230:57-70.
75. Konings M.K., Mali W.P.T.M., Viergever M.A. Development of an intravascular impedance catheter for detection of fatty lesions in arteries. IEEE Trans Med Imaging. 16:1997;439-446.
76. Pasterkamp G., Schoneveld A.H., van der Wal A.C., et al. Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary arteries. Arterioscl Thromb Vasc Biol. 19:1999;54-58.
77. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) . Lancet. 344:1994;1383-1389.
78. Leung W.H., Lau C.P., Wong C.K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolemic patients. Lancet. 341:1993;1496-1500.
79. Aikawa M., Rabkin E., Okada Y., et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma. Circulation. 97:1998;2433-2444.
80. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
81. Ritchie M.E. Nuclear Factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation. 98:1998;1707-1713.